Nishiyama, M <br/><br/>
Low-dose cisplatin and 5-fluorouracil in combination can repress increased gene expression of cellular resistance determinants to themselves.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Sep 1999 
 - 2620-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP-Binding Cassette Transporters--biosynthesis<br/>Adenocarcinoma--drug therapy<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Carcinoma, Renal Cell--drug therapy<br/>Cisplatin--administration & dosage<br/>Dihydrouracil Dehydrogenase (NADP)<br/>Dose-Response Relationship, Drug<br/>Drug Resistance, Multiple--genetics<br/>Drug Resistance, Neoplasm--genetics<br/>Drug Synergism<br/>Fluorouracil--administration & dosage<br/>Gastrointestinal Neoplasms--drug therapy<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Glutathione S-Transferase pi<br/>Glutathione Transferase--biosynthesis<br/>Humans<br/>Isoenzymes--biosynthesis<br/>K562 Cells--drug effects<br/>Kidney Neoplasms--drug therapy<br/>Multidrug Resistance-Associated Proteins<br/>Neoplasm Proteins--biosynthesis<br/>Oxidoreductases--biosynthesis<br/>Thymidylate Synthase--genetics<br/>Tumor Cells, Cultured